immatics biotechnologies
Paul-Ehrlich-Str. 15, Tuebingen, Germany
Company Profile
Industry:Biotechnology
Site:immatics.com
Description:immatics biotechnologies is an independent biopharmaceutical company dedicated to the rational development of novel active immunotherapies against cancer. immatics' therapeutic vaccines are based on multiple tumor-associated peptides (TUMAPs) which specifically stimulate the immune system against cancer cells. immatics has currently three products – IMA901 for the therapy of renal cell cancer, IMA910 for the treatment of colon cancer and IMA950 for the treatment of glioma – under clinical...
Specialties:Discovery and clinical development of peptide-based cancer vaccines, Biomarkers, Immunomonitoring, Pharmaceutical development of multi-peptide formulations, Standardized PBMC collection, Peptidomics & mass spectrometry, Immunology, Bioinformatics
Founded:2000
Company size:51-200 employees
Who has worked at immatics biotechnologies
Position at immatics biotechnologies | Previous job position | |
---|---|---|
Claudia Wagner | Scientist ImmunologySince May 2012 |
Yale University School of Medicinepostdoctoral fellow Oct 2007 - Jan 2012 |